“[Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]” (2026) Farmeconomia. Health Economics and Therapeutic Pathways, 27(1). doi:10.7175/fe.v27i1.1605.